Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059840/
https://www.ncbi.nlm.nih.gov/pubmed/35422426
http://dx.doi.org/10.1183/13993003.00166-2022
_version_ 1784698390443982848
collection PubMed
description Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6
format Online
Article
Text
id pubmed-9059840
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-90598402022-05-03 Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment Eur Respir J Editorials Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6 European Respiratory Society 2022-04-14 /pmc/articles/PMC9059840/ /pubmed/35422426 http://dx.doi.org/10.1183/13993003.00166-2022 Text en Copyright ©The authors 2022. https://creativecommons.org/licenses/by/4.0/This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
spellingShingle Editorials
Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
title Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
title_full Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
title_fullStr Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
title_full_unstemmed Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
title_short Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
title_sort updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059840/
https://www.ncbi.nlm.nih.gov/pubmed/35422426
http://dx.doi.org/10.1183/13993003.00166-2022
work_keys_str_mv AT updatingtheapproachestodefinesusceptibilityandresistancetoantituberculosisagentsimplicationsfordiagnosisandtreatment

Ejemplares similares